Prostate cancer nĩ mũrimũ ũrĩa ũnyitaga arũme mũno, na ũgwati waguo ũkongerereka na mĩaka.
Ũkoragwo ũnyitaga arũme arĩa makĩrĩte mĩaka 65.
Maũndũ mamwe marĩa mangĩtũma mũndũ akũrie kansa ya prostate nĩ:
1. Ũkũrũ: Mũrimũ wa kansa ya prostate wongererekaga o ũrĩa mũndũ arakũra, na kaingĩ ũgakora arũme arĩa makĩrĩte mĩaka 65.
2. Arĩa marĩ famĩlĩ-inĩ yao: Arũme arĩa marĩ na famĩlĩ ĩrĩ na mũrimũ wa kansa ya prostate, makĩria ithe kana mũrũ wa nyina, marĩ ũgwati-inĩ mũnene wa kũgĩa naguo.
3. Mũhĩrĩga: Arũme a kuuma Afrika na Amerika nĩ makoragwo ũgwati-inĩ mũnene wa kũgĩa na kansa ya prostate na kaingĩ makoragwo marĩ anini mũno na makoragwo na mũrimũ ũcio na ihenya mũno.
4. Maũndũ ma kĩĩmerera: Tũhengereta tũmwe tũrĩa tũkoragwo na mogarũrũku ta ma BRCA1 na BRCA2, no tũingĩhĩrie ũgwati wa mũndũ kũgĩa na kansa ya prostate.
5. Irio: Irio iria ciingĩhĩte nyama ndune na indo iria ithondeketwo na iria irĩ na maguta maingĩ no ciongerere ũgwati wa mũndũ kũgĩa na kansa ya prostate, nacio iria ciingĩhĩte matunda na mboga no ciũnyihie.
6. Ũritũ: Gũkorũo na ũritũ wa mwĩrĩ kana gũkorũo na ũritũ wa mwĩrĩ mũno no kuongerere ũgwati wa mũndũ kũgĩa na kansa ya prostate, o hamwe na ũhotekeku wa kansa ĩyo gũthũka na ihenya.
7. Maũndũ megiĩ mĩikarĩre: Maũndũ mamwe megiĩ mĩikarĩre, ta kũnyua thigara na kwaga kũnogora mwĩrĩ, no matũme mũndũ agĩe na ũgwati wa kũgĩa na kansa ya prostate.
Nĩ wega kũririkana atĩ o na gũtuĩka maũndũ macio no mongerere ũgwati wa mũndũ kũgĩa na prostate cancer, ti arũme othe arĩa marĩ na maũndũ macio mangĩgĩa na mũrimũ ũcio, na arũme amwe arĩa matarĩ na maũndũ macio no makorũo na prostate cancer.
Gũthimwo kaingĩ na kwarĩrĩria maũndũ marĩa ũreciria na ndagĩtarĩ no gũteithie kũmenya kansa ya prostate tene, rĩrĩa ĩngĩthondekeka.
Shimodaira K, Nakashima J, Nakagami Y, Hirasawa Y, Hashimoto T, Satake N, Gondo T, Namiki K, Ohori M, Ohno Y: Prognostic Value of Platelet Counts in Patients with Metastatic Prostate Cancer Treated with Endocrine Therapy. Urol J. 2020, 17 (1): 42-49.
Advanced prostate cancer gets a new foe. Johns Hopkins Med Lett Health After 50. 2013, 25 (7): 8.
Vera Badillo FE: Metastatic prostate cancer gets into the biomarker era. Can Urol Assoc J. 2022, 16 (10): 333.
Gerard MJ, Frank-Stromborg M: Screening for prostate cancer in asymptomatic men: clinical, legal, and ethical implications. Oncol Nurs Forum. 1998, 25 (9): 1561-9.
McDowell ME, Occhipinti S, Chambers SK: The influence of family history on cognitive heuristics, risk perceptions, and prostate cancer screening behavior. Health Psychol. 2013, 32 (11): 1158-69.
Razzaghi MR, Mazloomfard MM, Malekian S, Razzaghi Z: Association of macrophage inhibitory factor -173 gene polymorphism with biological behavior of prostate cancer. Urol J. 2019, 16 (1): 32-36.
['Ũkaana: thibitarĩ']
['Website ĩno ĩkoragwo ĩrĩ ya kũrutana na kũheana ũhoro tu na ti ya kũheana ũtaaro wa ũrigitani kana ũtungata wa kĩĩmwĩrĩ.']
['Ũhoro ũrĩa ũrĩ thĩinĩ wa broshua ĩyo ndwagĩrĩirũo kũhũthĩrũo gũthima kana kũrigita mũrimũ mũna, na arĩa marenda ũtaaro wa ũrigitani magĩrĩirũo gũcaria ũteithio wa ndagĩtarĩ.']
['No wone atĩ netiwaki ya neuron ĩrĩa ĩheanaga macokio ma ciũria icio, ndĩkoragwo na ũkinyanĩru mũno ũhoro-inĩ wĩgiĩ namba. Kwa ngerekano, mũigana wa andũ arĩa magwatĩtio mũrimũ mũna.']
['Hingo ciothe caria ũtaaro wa ndagĩtarĩ kana mũndũ ũngĩ wagĩrĩire ũgima-inĩ waku wa mwĩrĩ igũrũ rĩgiĩ mũrimũ. Ndũkaanahũthie ũtaaro wa ndagĩtarĩ kana ũcererũo kũũcaria nĩ ũndũ wa ũndũ ũthomete thĩinĩ wa website ĩno. Ũngĩkorũo ũrona ta wacemania na ũndũ mũhiũ, hũra thimũ 911 kana ũthiĩ thibitarĩ ya hakuhĩ na harĩa ũrĩ. Gũtirĩ ũrata wa ndagĩtarĩ na mũrwaru wonekaga nĩ ũndũ wa website ĩno kana kũhũthĩrũo kwayo. BioMedLib kana aruti ayo a wĩra, kana mũndũ ũngĩ wothe ũrutĩte wĩra thĩinĩ wa website ĩno, ndarĩ na ũira, wa ĩmwe kwa ĩmwe kana wa ĩmwe kwa ĩmwe, wĩgiĩ ũhoro ũrĩa ũheanĩtwo ho kana ũrĩa ũhũthĩrĩtwo.']
['Ũregani: wĩyathi wa kwandĩka']
['Watho wa Digital Millennium Copyright Act wa 1998, 17 U.S.C. § 512 (the DMCA) ũheanaga ũhoti wa ene a ihoto cia wandĩki arĩa metĩkĩtie atĩ ũhoro ũrĩa ũroneka intanetiinĩ nĩ ũtharĩtie ihooto ciao kũringana na watho wa U.S. wa ihoto cia wandĩki.']
['Ũngĩkorũo na wĩtĩkio atĩ ũhoro kana kĩndũ kĩna gĩtahingũrĩtwo ũhoro-inĩ wĩgiĩ website kana ũtungata witũ nĩ gĩgũthũkia ihooto ciaku, wee (kana mũndũ ũrĩa ũgũgũthondekera) no ũtũtũmĩre notithi ũkĩũria ũhoro kana kĩndũ kĩu kĩeherio, kana ũrigĩrĩrio ndũgacihũthĩre.']
["Marũa macio magĩrĩire gũtũmwo na njĩra ya kwandĩkwo na e-mail (rora ũhoro wa andirethi gĩcunjĩinĩ kĩa 'Maũndũ ma kwaranĩria')."]
['DMCA ĩbataraga atĩ notithi yaku ya kuuna ihooto cia wandĩki ĩkorwo na ũhoro ũyũ: (1) ũtaarĩria wa wĩra ũrĩa ũrĩ na ihooto cia wandĩki ũrĩa ũrarumwo; (2) ũtaarĩria wa ũhoro ũrĩa ũrarumwo na ũhoro mũiganu wa gũtũhotithia kũmenya kũrĩa ũhoro ũcio ũrĩ; (3) ũhoro waku wa kwaranĩria, hamwe na andirethi, namba ya thimũ na andirethi ya e-mail; (4) ndũmĩrĩri yaku atĩ wĩ na wĩtĩkio mwega atĩ ũhoro ũcio ũramenererio ndũrĩ na rũtha rwa mwene wa watho, kana mũrũgamĩrĩri, kana rwa watho o wothe; ']
['(5) nĩ mwandĩkanĩire, na nĩ mũkũheo mũkaana wa kũheenania, atĩ ũhoro ũrĩa ũrĩ kĩmenyithiainĩ kĩu nĩ wa ma na atĩ mũrĩ na ũhoti wa kũhingia ihooto iria mũreganĩte nacio;']
['na (6) kĩrore kĩa mwene kĩhoto kana kĩa mũndũ wĩtĩkĩritio gwĩtongoria handũ ha mwene kĩhoto.']
['Kwaga kwandĩka ũhoro ũcio wothe no gũtũme gũtangĩka gwaku kũhĩtũke.']
['Ũhoro wa Kwaranĩria']
['Tũma ndũmĩrĩri ya kũbucia kũgerera thimũ kana thimũ ya mohoro.']
Who gets prostate cancer?
Prostate cancer is a disease that primarily affects men, with the risk increasing with age.
It is most commonly diagnosed in men over the age of 65.
Some factors that may increase the risk of developing prostate cancer include:
1. Age: The risk of prostate cancer increases with age, with most cases occurring in men over the age of 65.
2. Family history: Men with a family history of prostate cancer, particularly a father or brother with the disease, have a higher risk of developing prostate cancer themselves.
3. Race: African American men have a higher risk of developing prostate cancer and are more likely to be diagnosed at a younger age and with more aggressive forms of the disease.
4. Genetics: Certain inherited genetic mutations, such as those in the BRCA1 and BRCA2 genes, may increase the risk of developing prostate cancer.
5. Diet: A diet high in red meat and high-fat dairy products may increase the risk of prostate cancer, while a diet rich in fruits and vegetables may decrease the risk.
6. Obesity: Being overweight or obese may increase the risk of developing prostate cancer, as well as the likelihood of the cancer being more aggressive.
7. Lifestyle factors: Certain lifestyle factors, such as smoking and lack of physical activity, may increase the risk of developing prostate cancer.
It is important to note that while these factors may increase the risk of developing prostate cancer, not all men with these risk factors will develop the disease, and some men without any known risk factors may still be diagnosed with prostate cancer.
Regular screening and discussing any concerns with a healthcare provider can help to detect prostate cancer early, when it is most treatable.
Disclaimer: medical
This web site is provided for educational and informational purposes only and does not constitute providing medical advice or professional services.
The information provided should not be used for diagnosing or treating a health problem or disease, and those seeking personal medical advice should consult with a licensed physician.
Please note the neural net that generates answers to the questions, is specially inaccurate when it comes to numeric content. For example, the number of people diagnosed with a specific disease.
Always seek the advice of your doctor or other qualified health provider regarding a medical condition. Never disregard professional medical advice or delay in seeking it because of something you have read on this website. If you think you may have a medical emergency, call 911 or go to the nearest emergency room immediately. No physician-patient relationship is created by this web site or its use. Neither BioMedLib nor its employees, nor any contributor to this web site, makes any representations, express or implied, with respect to the information provided herein or to its use.
Disclaimer: copyright
The Digital Millennium Copyright Act of 1998, 17 U.S.C. § 512 (the “DMCA”) provides recourse for copyright owners who believe that material appearing on the Internet infringes their rights under U.S. copyright law. If you believe in good faith that any content or material made available in connection with our website or services infringes your copyright, you (or your agent) may send us a notice requesting that the content or material be removed, or access to it blocked. Notices must be sent in writing by email (see 'Contact' section for email address) . The DMCA requires that your notice of alleged copyright infringement include the following information: (1) description of the copyrighted work that is the subject of claimed infringement; (2) description of the alleged infringing content and information sufficient to permit us to locate the content; (3) contact information for you, including your address, telephone number and email address; (4) a statement by you that you have a good faith belief that the content in the manner complained of is not authorized by the copyright owner, or its agent, or by the operation of any law; (5) a statement by you, signed under penalty of perjury, that the information in the notification is accurate and that you have the authority to enforce the copyrights that are claimed to be infringed; and (6) a physical or electronic signature of the copyright owner or a person authorized to act on the copyright owner’s behalf. Failure to include all of the above information may result in the delay of the processing of your complaint.
['Ũhoro wa']
['BioMedLib ĩhũthagĩra kombiuta cia gwĩthuurĩra (njĩra cia gũthoma macini) gũthondeka ciũria na macokio.']
['Twambĩrĩirie na mabuku milioni 35 megiĩ ũgima wa mwĩrĩ marĩa makoragwo thĩinĩ wa PubMed/Medline. Ningĩ, tũhũthagĩra ciarĩro cia RefinedWeb.']
